Overview
Mediphage (Toronto) is a genomics company that has created trademark DNA technology to improve the quality of key ingredients in genetic medicines.
What they’re doing: Their research-grade msDNAᵀᴹ platform is being used to develop genetic medicines that can help people with hard-to-treat conditions like hemophilia and other chronic and genetic diseases.
How will this be used in the real world? Science is getting us closer to personalized medicine and Mediphage’s DNA technology is aiming to make genetic therapies that are much more effective to meet the growing commercial demand for quality ingredients to create new DNA-based treatments.